Sanofi annual capital expenditures (capex)
2018
2019
2020
2021
2022
2023
2024
2025
Sanofi Capital Expenditures (CapEx) Growth & History (SAN)
Sanofi's capital expenditures (capex) was €3.54B for fiscal 2025.
View full Sanofi company overviewSanofi annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €3.54B | €343.0M | +10.74% |
| 2024 | 2024-12-31 | €3.19B | €289.0M | +9.94% |
| 2023 | 2023-12-31 | €2.91B | €803.0M | +38.18% |
| 2022 | 2022-12-31 | €2.10B | €60.0M | +2.94% |
| 2021 | 2021-12-31 | €2.04B | −€40.0M | −1.92% |
| 2020 | 2020-12-31 | €2.08B | €296.0M | +16.56% |
| 2019 | 2019-12-31 | €1.79B | −€190.0M | −9.61% |
| 2018 | 2018-12-31 | €1.98B | — | — |
Sanofi capital expenditures (capex) trends
Over the last five fiscal years, Sanofi's capital expenditures (capex) increased from €2.08B to €3.54B, a change of €1.46B.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sanofi source filings ↗